Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Introduction: Complete pathologic response (CPR) is an acceptable surrogate for survival in clinical trials but it occurs infrequently in patients with NSCLC receiving neoadjuvant chemotherapy (NCT). Therefore, we studied the impact of major pathologic response (MPR) for predicting survival of patie...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Apar Pataer, MD, PhD, Annikka Weissferdt, MD, Arlene M. Correa, PhD, Ara A. Vaporciyan, MD, Boris Sepesi, MD, John V. Heymach, MD, Sabina Berezowska, MD, Tina Cascone, MD, Stephen G. Swisher, MD
Format: Artikel
Sprache:English
Veröffentlicht: Elsevier 2022-11-01
Schriftenreihe:JTO Clinical and Research Reports
Schlagworte:
Lung cancer
Neoadjuvant chemotherapy
Major pathologic response
Non–small cell lung cancer
Online Zugang:http://www.sciencedirect.com/science/article/pii/S2666364322001448

Online

http://www.sciencedirect.com/science/article/pii/S2666364322001448

Ähnliche Einträge